{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:34:53Z","timestamp":1764401693972},"reference-count":50,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31670933","81601762"],"award-info":[{"award-number":["31670933","81601762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.03.065","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T01:34:09Z","timestamp":1491874449000},"page":"2728-2735","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus"],"prefix":"10.1016","volume":"35","author":[{"given":"Yangtao","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfa","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.03.065_b0005","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: implications for control through routine immunization","volume":"70","author":"Kilgore","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0010","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2990.2011.01167.x","article-title":"Review: the neurobiology of varicella zoster virus infection","volume":"37","author":"Gilden","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0015","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Diseases"},{"key":"10.1016\/j.vaccine.2017.03.065_b0020","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group","volume":"341","author":"Ho","year":"1999","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2017.03.065_b0025","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3201\/eid1301.020112","article-title":"Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore","volume":"9","author":"Chan","year":"2003","journal-title":"Emerg Infect Diseases"},{"key":"10.1016\/j.vaccine.2017.03.065_b0030","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12250-011-3195-8","article-title":"Hand foot and mouth disease due to enterovirus 71 in Malaysia","volume":"26","author":"Chua","year":"2011","journal-title":"Virol Sinica"},{"key":"10.1016\/j.vaccine.2017.03.065_b0035","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3201\/eid1812.120929","article-title":"Enterovirus 71-associated hand, foot, and mouth disease, Southern Vietnam, 2011","volume":"18","author":"Khanh","year":"2012","journal-title":"Emerg Infect Diseases"},{"key":"10.1016\/j.vaccine.2017.03.065_b0040","doi-asserted-by":"publisher","first-page":"e96051","DOI":"10.1371\/journal.pone.0096051","article-title":"Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.03.065_b0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.vaccine.2017.03.065_b0050","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3892\/mmr.2012.742","article-title":"Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China","volume":"5","author":"Chen","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.vaccine.2017.03.065_b0055","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/rmv.1827","article-title":"Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014","volume":"25","author":"Liu","year":"2015","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0060","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12985-015-0308-2","article-title":"Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis","volume":"12","author":"Wang","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.03.065_b0065","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/INF.0000000000000194","article-title":"Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care","volume":"33","author":"Zhang","year":"2014","journal-title":"Pediat Infect Disease J"},{"key":"10.1016\/j.vaccine.2017.03.065_b0070","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/1743-422X-8-508","article-title":"Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009","volume":"8","author":"Yang","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.03.065_b0075","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/00365548.2011.634433","article-title":"Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16","volume":"44","author":"Yan","year":"2012","journal-title":"Scandinavian J Infect Diseases"},{"key":"10.1016\/j.vaccine.2017.03.065_b0080","first-page":"1","article-title":"The varicella-zoster virus genome","volume":"342","author":"Cohen","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.03.065_b0085","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Diseases"},{"key":"10.1016\/j.vaccine.2017.03.065_b0090","doi-asserted-by":"publisher","first-page":"e82861","DOI":"10.1371\/journal.pone.0082861","article-title":"Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified","volume":"8","author":"Chen","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.03.065_b0095","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Diseases"},{"key":"10.1016\/j.vaccine.2017.03.065_b0100","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2017.03.065_b0105","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2017.03.065_b0110","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.03.065_b0115","article-title":"EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)","volume":"1\u20138","author":"Mao","year":"2016","journal-title":"Exp Rev Vacc"},{"issue":"7","key":"10.1016\/j.vaccine.2017.03.065_b0120","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/14760584.2016.1191357","article-title":"Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine","volume":"15","author":"Zhou","year":"2016","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.03.065_b0125","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","article-title":"Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model","volume":"27","author":"Zhou","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.065_b0130","first-page":"107","article-title":"Novel approaches to foot-and-mouth disease vaccine development","volume":"135","author":"Ludi","year":"2013","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0168-1656(95)00118-2","article-title":"Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. Presentation of foreign epitopes","volume":"44","author":"Schodel","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0140","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000150481","article-title":"Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety","volume":"39","author":"Schodel","year":"1996","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2017.03.065_b0145","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1007\/s00253-015-6602-5","article-title":"A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine","volume":"99","author":"Liu","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0150","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.vaccine.2016.02.007","article-title":"A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice","volume":"34","author":"Zhu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.065_b0155","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1743-422X-9-26","article-title":"Enterovirus 71 viral capsid protein linear epitopes: identification and characterization","volume":"9","author":"Gao","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.03.065_b0160","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.03.065_b0165","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1743-422X-9-55","article-title":"Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein","volume":"9","author":"Kiener","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.03.065_b0170","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.065_b0175","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/thno.7457","article-title":"Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop","volume":"4","author":"Xu","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.vaccine.2017.03.065_b0180","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0185","doi-asserted-by":"publisher","first-page":"12973","DOI":"10.1038\/srep12973","article-title":"A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71","volume":"5","author":"Xu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.03.065_b0190","doi-asserted-by":"publisher","first-page":"e41381","DOI":"10.1371\/journal.pone.0041381","article-title":"Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon","volume":"7","author":"Tian","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.03.065_b0195","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3748\/wjg.v11.i4.492","article-title":"Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus","volume":"11","author":"Yang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0200","doi-asserted-by":"publisher","first-page":"e109391","DOI":"10.1371\/journal.pone.0109391","article-title":"In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.03.065_b0205","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1038\/emi.2016.73","article-title":"EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases","volume":"5","author":"Mao","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2017.03.065_b0210","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMoa065954","article-title":"Neurodevelopment and cognition in children after enterovirus 71 infection","volume":"356","author":"Chang","year":"2007","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2017.03.065_b0215","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3346\/jkms.2013.28.2.195","article-title":"Seroepidemiology of varicella-zoster virus in Korea","volume":"28","author":"Lee","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2017.03.065_b0220","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.1128\/JVI.00422-15","article-title":"Crystal structures of yeast-produced enterovirus 71 and enterovirus 71\/coxsackievirus A16 chimeric virus-like particles provide the structural basis for novel vaccine design against hand-foot-and-mouth disease","volume":"89","author":"Lyu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.03.065_b0225","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1743-422X-11-79","article-title":"Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice","volume":"11","author":"Li","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.03.065_b0230","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-015-0181-8","article-title":"Japanese encephalitis virus replicon-based vaccine expressing enterovirus-71 epitope confers dual protection from lethal challenges","volume":"22","author":"Huang","year":"2015","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2017.03.065_b0235","doi-asserted-by":"publisher","first-page":"25741","DOI":"10.1038\/srep25741","article-title":"A modular vaccine development platform based on sortase-mediated site-specific tagging of antigens onto virus-like particles","volume":"6","author":"Tang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.03.065_b0240","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1006\/viro.1995.0064","article-title":"Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus","volume":"214","author":"Fowler","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.03.065_b0245","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0264-410X(96)00228-9","article-title":"Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)","volume":"15","author":"Garcia-Valcarcel","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.065_b0250","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"New England J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:41:38Z","timestamp":1692758498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":50,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17303924"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}